UK markets closed

Lucira Health, Inc. (LHDX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.00-0.53 (-5.03%)
As of 11:59AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close10.53
Open10.41
Bid9.76 x 1100
Ask9.78 x 900
Day's range9.53 - 10.46
52-week range4.23 - 37.99
Volume247,903
Avg. volume2,391,306
Market cap385.734M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-6.48
Earnings date12 Aug 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est8.50
  • Will Lucira Health (NASDAQ:LHDX) Spend Its Cash Wisely?
    Simply Wall St.

    Will Lucira Health (NASDAQ:LHDX) Spend Its Cash Wisely?

    There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

  • 2 Under-the-Radar Stocks to Buy Now
    Motley Fool

    2 Under-the-Radar Stocks to Buy Now

    COVID-19 testing company Lucira Health became public only in February, but it has been plagued by problems since. Lucira's flagship device is a single-use, do-it-yourself COVID-19 test kit that received regulatory clearance for over-the-counter use in April. Overall, it was a major innovation by Lucira Health, but it came a tad bit too late.

  • 5 Stocks to Own for the Surge in Coronavirus Variants
    Motley Fool

    5 Stocks to Own for the Surge in Coronavirus Variants

    Although the pandemic has mostly faded from the front pages, mutations of the SARS-CoV-2 virus are increasing the odds that COVID will make a resurgence this winter. Add in many Americans' hesitancy over vaccines, and it appears the companies providing testing, treatments, and vaccine boosters could remain a part of our lives longer than it seemed only a few months ago. Revenue rose 1,200% on the back of a 74-fold increase in testing volume.